Enlivex Therapeutics: HC Wainwright Raises Buy Rating to $13, PT Elevated

lunes, 12 de enero de 2026, 6:31 am ET1 min de lectura
ENLV--

Enlivex Therapeutics: HC Wainwright Raises Buy Rating to $13, PT Elevated

Enlivex Therapeutics: HC Wainwright Raises Buy Rating to $13, PT Elevated

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios